Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin anti-Xa monitoring in critically ill ICU patients
NL-OMON33800Recruiting
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Jul 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of nadroparin in venous thromboembolism (VTE), sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: Anti-Xa activity. Started Jul 2009; status: recruiting.
02
Drugs
nadroparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NL-OMON33800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33800.